{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:45Z","timestamp":1761986505361,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaad.2016.12.032","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T02:00:20Z","timestamp":1502503220000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Etiologies and management of cutaneous flushing"],"prefix":"10.1016","volume":"77","author":[{"given":"Azeen","family":"Sadeghian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey","family":"Rouhana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Oswald-Stumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Boh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.12.032_bib1","first-page":"55","article-title":"Mastocytosis","volume":"Vol. 2","author":"Horny","year":"2008"},{"key":"10.1016\/j.jaad.2016.12.032_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.iac.2013.09.001","article-title":"Mastocytosis","volume":"34","author":"Carter","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib3","first-page":"3047","article-title":"Cutaneous and systemic manifestations of mastocytosis","volume":"59","author":"Alto","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2016.12.032_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaad.2016.12.032_bib5","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1523-1747.ep12606209","article-title":"Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2","volume":"104","author":"Morrow","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.12.032_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Akin","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.hoc.2012.08.008","article-title":"New insights into the pathogenesis, diagnosis, and management of mastocytosis","volume":"26","author":"Fuller","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.leukres.2005.11.014","article-title":"Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1\/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib","volume":"30","author":"Florian","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2016.12.032_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-5122(97)83974-6","article-title":"Differential diagnosis of hot flashes","volume":"27","author":"Mohyi","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.jaad.2016.12.032_bib12","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/archinte.1988.00380120074015","article-title":"Distinguishing features of idiopathic flushing and carcinoid syndrome","volume":"148","author":"Aldrich","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jaad.2016.12.032_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1634\/theoncologist.2013-0053","article-title":"Current understanding and management of medullary thyroid cancer","volume":"18","author":"Roy","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2016.12.032_bib15","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1210\/jc.2014-1278","article-title":"Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer","volume":"99","author":"Machens","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2016.12.032_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11906-014-0442-z","article-title":"Diagnosis and management of pheochromocytoma: a practical guide to clinicians","volume":"16","author":"Pappachan","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jaad.2016.12.032_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2007.04.012","article-title":"Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment","volume":"21","author":"Mittendorf","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-95-4-468","article-title":"Flushing reactions: consequences and mechanisms","volume":"95","author":"Wilkin","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2016.12.032_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0196-9781(89)90097-1","article-title":"Calcitonin gene-related peptide-like immunoreactivities in pheochromocytomas","volume":"10","author":"Mouri","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.jaad.2016.12.032_bib21","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/ol.2015.3660","article-title":"Plasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytoma","volume":"10","author":"Hu","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jaad.2016.12.032_bib22","first-page":"241","article-title":"Adrenomedullin and endocrine disorders","volume":"45","author":"Letizia","year":"2003","journal-title":"Panminerva Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0196-9781(01)00508-3","article-title":"Bioactivity of\u00a0adrenomedullin and proadrenomedullin N-terminal 20 peptide in man","volume":"22","author":"Nicholls","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.jaad.2016.12.032_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2016.12.032_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1067\/j.cpsurg.2006.03.002","article-title":"Carcinoid tumors","volume":"43","author":"Raut","year":"2006","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.jaad.2016.12.032_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bpg.2012.12.002","article-title":"Neuroendocrine tumours of the small intestine","volume":"26","author":"Strosberg","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2016.12.032_bib27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bpg.2012.12.006","article-title":"Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)","volume":"26","author":"Kanakis","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2016.12.032_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"152","author":"Bell","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.032_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200607020-00001","article-title":"Cutaneous manifestations of internal malignancy: diagnosis and management","volume":"7","author":"Kleyn","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2016.12.032_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.seminoncol.2012.11.003","article-title":"Systemic therapeutic options for carcinoid","volume":"40","author":"Pavel","year":"2013","journal-title":"Semin Oncol"},{"issue":"pt 6","key":"10.1016\/j.jaad.2016.12.032_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1258\/000456303770367207","article-title":"The spectrum of carcinoid tumours and carcinoid syndromes","volume":"40","author":"Lips","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jaad.2016.12.032_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1148\/radiographics.14.2.8190965","article-title":"Bronchogenic carcinoma: radiologic-pathologic correlation","volume":"14","author":"Rosado-de-Christenson","year":"1994","journal-title":"Radiographics"},{"key":"10.1016\/j.jaad.2016.12.032_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM197507242930401","article-title":"Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors","volume":"293","author":"Said","year":"1975","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.jaad.2016.12.032_bib34","first-page":"201S","article-title":"Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept","volume":"5","author":"Said","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaad.2016.12.032_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.31.6.591","article-title":"Ectopic ACTH syndrome: clinicopathological correlations","volume":"31","author":"Singer","year":"1978","journal-title":"J Clin Pathol"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2016.12.032_bib36","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/annonc\/12.suppl_2.S95","article-title":"Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours","volume":"12","author":"Tomassetti","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2016.12.032_bib37","first-page":"e129","article-title":"VIPoma syndrome: challenges in management","volume":"51","author":"Adam","year":"2010","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2016.12.032_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/07435800.2010.525085","article-title":"Pancreatic neuroendocrine tumors","volume":"36","author":"Batcher","year":"2011","journal-title":"Endocr Res"},{"key":"10.1016\/j.jaad.2016.12.032_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","article-title":"Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2016.12.032_bib40","first-page":"282","article-title":"VIPoma syndrome","volume":"14","author":"Mekhjian","year":"1987","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2016.12.032_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(87)90425-6","article-title":"VIPoma syndrome","volume":"82","author":"Krejs","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5694\/j.1326-5377.2010.tb03742.x","article-title":"Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management","volume":"193","author":"Modlin","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2016.12.032_bib43","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.jaad.2016.12.032_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000421-199906000-00003","article-title":"Renal cell carcinoma: a paradigm of lanthanic disease","volume":"22","author":"Papac","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2016.12.032_bib46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.1980.00330190107032","article-title":"A carcinoid-like syndrome caused by a prostaglandin-secreting renal cell carcinoma","volume":"140","author":"Plaksin","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2016.12.032_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hoc.2011.05.001","article-title":"Future directions in renal cell carcinoma: 2011 and beyond","volume":"25","author":"Cho","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2016.12.032_bib48","first-page":"290","article-title":"Systemic therapy in renal cell carcinoma: advancing paradigms","volume":"26","author":"Posadas","year":"2012","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jaad.2016.12.032_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaad.2005.07.057","article-title":"The flushing patient: differential diagnosis, workup, and treatment","volume":"55","author":"Izikson","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:42:45Z","timestamp":1759272165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216312932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0190962216312932"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.032","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiologies and management of cutaneous flushing","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(17)32124-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}